CSF2RB and myeloid sarcoma: The analysis of genetic data published on genome-wide association studies (GWAS) Catalog from the National Human Genome Research Institute (NHGRI) Catalog shows that CSF2RB has susceptibility variants for MS (12) (Supplementary Table 2).